Coxsackievirus can persist in murine pancreas by deletion of 5′ terminal genomic sequences

Journal of Medical Virology

Volumn 87, Issue 2, 2015, Pages 240-247

  Tracy, Steven ^a   Smithee, Shane ^a   Alhazmi, Abdulaziz ^a   Chapman, Nora ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Coxsackievirus B3; Persistence; Terminally deleted genome; Type 1 diabetes

Indexed keywords

GENOMIC RNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOPATHOGENIC EFFECT; ENTEROVIRUS INFECTION; FEMALE; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN CELL; INOCULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PROTEIN SECONDARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; ANIMAL; ENTEROVIRUS B; GENETICS; PHYSIOLOGY; VIROLOGY; VIRULENCE; VIRUS LATENCY;

COXSACKIEVIRUS; ENTEROVIRUS; MURINAE; MUS;

ANIMALS; ENTEROVIRUS B, HUMAN; FEMALE; MICE, INBRED NOD; PANCREAS; SEQUENCE DELETION; VIRULENCE; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84919860469     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24039     Document Type: Article

References (58)

1. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip . M. 2002. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115:18-29.
2. Andino R, Rieckhof GE, Achacoso PL, Baltimore D. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J 12:3587-3598.
3. Andreoletti L, Hober D, Hober-Vandenberghe C, Belaich S, Vantyghem MC, Lefebvre J, Wattre P. 1997. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 52:121-127.
4. Archard LC, Khan MA, Soteriou BA, Zhang H, Why HJ, Robinson NM, Richardson PJ. 1998. Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578-584.
5. Atkinson MA, Leiter EH. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med 5:601-604.
6. Atkinson MA, Eisenbarth GS. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229.
7. Baboonian C, Davies MJ, Booth JC, McKenna WJ. 1997. Coxsackie B viruses and human heart disease. Curr Topcs Microbiol 223:13-30.
8. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich . SS. 2009. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat genet 41:703-707.
9. Barton DJ, O'Donnell BJ, Flanegan JB. 2001. 5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis. EMBO J 20:1439-1448.
10. Bonderoff JM, Lloyd RE. 2008. CVB translation: lessons from poliovirus. Curr Top Microbiol 323:123-148.
11. Chapman NM, Kim KS. 2008. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol 323:275-292.
12. Chapman NM, Coppieters K, von Herrath M, Tracy S. 2012. The microbiology of human hygiene and its impact on type 1 diabetes. Islets 4:253-261.
13. Chapman NM, Kim KS, Drescher KM, Oka K, Tracy S. 2008. 5′ terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virol 375:480-491.
14. Clements GB, Galbraith DN, Taylor KW. 1995. Coxsackie B virus infection and onset of childhood diabetes. Lancet 346:221-223.
15. Coppieters KT, Boettler T, von Herrath M. 2012. Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med 2:a007682.
16. De Jager H, Van Creveld S. 1956. Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data. Annales paediatrici. Int Rev Pediat 187:100-118.
17. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. 2004. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virol 329:381-394.
18. Filippi CM, Estes EA, Oldham JE, von Herrath MG. 2009. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Inevst 119:1515-1523.
19. Gamarnik AV, Andino R. 1998. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Develop 12:2293-2304.
20. Gauntt C, Huber S. 2003. Coxsackievirus experimental heart diseases. Front Biosci 8:e23-35.
21. Haller MJ, Atkinson MA, Schatz D. 2005. Type 1 diabetes mellitus: etiology, presentation, and management. Ped Clin N Am 52:1553-1578.
22. Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. 2006. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 80:5637-5643.
23. Kibrick S, Benirschke K. 1958. Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent. Pediatr 22:857-875.
24. Kim KS, Chapman NM, Tracy S. 2008. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J Virol 82:2033-2037.
25. Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM. 2005. 5′-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024-7041.
26. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314-318.
27. Knowles N. 2014. Nick Knowles' Virus Pages. http://www.iah-virus.org/
28. Knowles N, Hovi T, Hyypia T, King A, Lindberg AM, Pallansch M, Palmenberg AC, Simmonds P, Skern T, Stanway G, Yamashita T, Zell . R. 2012. Picornaviridae. pp. 855-880. In: A, King M, Adams E, Carstens E, Lefkowitz, (eds.), Virus taxonomy: Classification and nomenclature of viruses: Ninth report of the international committee on taxonomy of viruses. Elsevier: San Diego.
29. Knowlton KU. 2008. CVB infection and mechanisms of viral cardiomyopathy. pp. 315-336. In: MSOS, Tracy KM, Drescher, (eds.), Group B coxsackieviruses vol. 323 Springer Verlag: Heidelberg.
30. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970.
31. Leveque N, Renois F, Talmud D, Nguyen Y, Lesaffre F, Boulagnon C, Bruneval P, Fornes P, Andreoletti L. 2012. Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy. J Clin Microbiol 50:3378-3380.
32. Maria H, Elshebani A, Orn A, Tuvemo T, Frisk G. 2005. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection. J Clin Virol 33:158-167.
33. Martino T, Liu P, Petric M, Sole . M. 1995. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. pp. 291-352. In: HA, Rotbart, (ed.) Human enterovirus infections. ASM Press: Washington, D.C.
34. Pallansch M, Oberste MS, Whitton JL. 2013. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses., pp. 490-530. In: DM, Knipe PM, Howley, (eds.) Fields virology, vol. 1, 6 ed. Wolters Kluwer: Philadelphia.
35. Palmenberg AC, Rathe JA, Liggett SB. 2010. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol 125:1190-1199 quiz 1200-1191.
36. Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL. 1997. Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 3:1124-1134.
37. Pauschinger M, Phan MD, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP. 1999. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889-895.
38. Pugliese A. 2013. The multiple origins of Type 1 diabetes. Diab Med 30:135-146.
39. Rey L, Lambert V, Wattre P, Andreoletti L. 2001. Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay. J Med Virol 64:133-140.
40. Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. 2013. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56:185-193.
41. Romero J. 2008. Pediatric group B coxsackievirus infections. Curr Top Microbiol 323:223-239.
42. Salvatoni A, Baj A, Bianchi G, Federico G, Colombo M, Toniolo A. 2013. Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes. Pediatr Diabetes 14:407-416.
43. Sean P, Semler BL. 2008. Coxsackievirus B RNA replication: lessons from poliovirus. Curr Top Microbiol 323:89-122.
44. Sharma N, Ogram SA, Morasco BJ, Spear A, Chapman NM, Flanegan JB. 2009. Functional role of the 5' terminal cloverleaf in Coxsackievirus RNA replication. Virol 393:238-249.
45. Steil BP, Barton DJ. 2009. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res 139:240-252.
46. Tam PE, Schmidt AM, Ytterberg SR, Messner RP. 1991. Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654-6660.
47. Teterina NL, Egger D, Bienz K, Brown DM, Semler BL, Ehrenfeld E. 2001. Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol 75:3841-3850.
48. Tracy S, Drescher KM, Chapman NM. 2011. Enteroviruses and type 1 diabetes. Diabet Metab Res 27:820-823.
49. Tracy S, Drescher KM, Jackson JD, Kim K, Kono . K. 2010. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 20:106-116.
50. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. 2000. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70-81.
51. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS. 2002. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097-12111.
52. von Herrath M, Filippi C, Coppieters K. 2011. How viral infections enhance or prevent type 1 diabetes-from mouse to man. J Med Virol 83:1672.
53. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC. 1994. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582-2589.
54. Wiegand V, Tracy S, Chapman N, Wucherpfennig C. 1990. Enteroviral infection in end stage dilated cardiomyopathy. Klin Wochenschr 68:914-920.
55. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. 2011. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 54:2417-2420.
56. Xiang W, Harris KS, Alexander L, Wimmer E. 1995. Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J Virol 69:3658-3667.
57. Yeung WC, Rawlinson WD, Craig ME. 2011. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35.
58. Yin H, Berg AK, Tuvemo T, Frisk G. 2002. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964-1971.